Vivos (RDGL) Return on Assets Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -1.00 |
| Mar 31, 2024 | -2.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 5.00 |
| Dec 31, 2022 | 12.00 |
| Sep 30, 2022 | -205.00 |
| Jun 30, 2022 | 22.00 |
| Mar 31, 2022 | 189.00 |
| Dec 31, 2021 | 545.00 |
| Sep 30, 2021 | 3,664.00 |
| Jun 30, 2021 | 2,576.00 |
| Mar 31, 2021 | 842.00 |
| Dec 31, 2020 | 282.00 |
| Sep 30, 2020 | 11.00 |
| Dec 31, 2019 | 152.00 |
| Sep 30, 2019 | 327.00 |
| Jun 30, 2019 | 37.00 |
| Mar 31, 2019 | -187.00 |
| Dec 31, 2018 | -583.00 |
| Sep 30, 2018 | -3,565.00 |
| Jun 30, 2018 | -2,493.00 |
| Mar 31, 2018 | -661.00 |
| Dec 31, 2017 | -136.00 |
| Sep 30, 2017 | 2.00 |
| Jun 30, 2017 | 6.00 |
| Mar 31, 2017 | -118.00 |
| Dec 31, 2016 | -156.00 |
| Sep 30, 2016 | -111.00 |
| Jun 30, 2016 | -48.00 |
| Mar 31, 2016 | 6.00 |
| Dec 31, 2015 | 47.00 |
| Sep 30, 2015 | -92.00 |
| Jun 30, 2015 | -78.00 |
| Mar 31, 2015 | -179.00 |
| Dec 31, 2014 | -145.00 |
| Sep 30, 2014 | -17.00 |